Tag: JAK inhibitor
Baricitinib for Granulomatosis with Polyangiitis: Mechanism, Evidence & Treatment Guide
Explore how baricitinib, a JAK inhibitor, could change treatment for Granulomatosis with Polyangiitis, covering mechanism, trial data, comparisons, dosing, and patient selection.